Where does Stimusil's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Stimusil's 3 recorded funding rounds.

Premier Alternatives

Stimusil

Wilmington, DE · Founded 2021 · Privately Held (backing)

Operator of a medical device company intended to develop proprietary methods for subdermal photobiomodulation. Stimusil is based in Wilmington, DE and was founded in 2021. Its last reported valuation was $29.2 million in Aug 2023. It has raised $10.3 million across 3 recorded rounds; the latest was a $599,988 seed round in Dec 2024.

Last reported valuation

$29.2M

Oct 2026

Priced at

—

Total raised

$10.3M

Last round

Seed Round

Dec 2024

Cap table — not yet on record

Stimusil's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Stimusil with a free account

·Watch Stimusil: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Stimusil

Where does Stimusil's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Stimusil's 3 recorded funding rounds.